Hong Kong SAR China · Who invested in Ascentage Pharma?
Ascentage Pharma's investors include Yuanming Capital, EFung Capital, Grains Valley Venture Capital, BioVenture Capital and Oriza Seed Capital.
20162017
$16MSeries A$72MSeries B
Hong Kong SAR China · Series B startup
Who invested in Ascentage Pharma
Funding summaryUpdated 26 Oct 2026
$88Mraised across 2 rounds since 2015, from 2 sources
$16MSeries A$72MSeries B
- Latest round
- Series B, $72MJan 2017
- Step-upi
- 4.6×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $16M Aug 2015
- Biggest round
- $72M Series B · Jan 2017
- Between rounds
- 17 months from the last two
The rounds
- Jan 2017
- Aug 2015Series A$16M5 new
Yuanming Capital
EFung Capital
Grains Valley Venture Capital- BioVenture Capital
- Oriza Seed Capital
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2015Series B2017Yuanming CapitalEFung CapitalGrains Valley Venture CapitalBioVenture CapitalOriza Seed Capital
Yuanming CapitalEFung CapitalGrains Valley Venture CapitalBioVenture CapitalOriza Seed CapitalEveryone who backed them
BioVenture Capitalno record of our own yet1round
Oriza Seed Capitalno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ascentage Pharma
How much has Ascentage Pharma raised?
Ascentage Pharma has raised $88M across 2 rounds since 2015.
When did Ascentage Pharma last raise?
Ascentage Pharma's most recent round was a Series B of $72M in Jan 2017.
What was Ascentage Pharma's biggest round?
Its most recent round, $72M in Jan 2017, is also its largest on record.
Who backed Ascentage Pharma first?
Ascentage Pharma's first round on record, in Aug 2015, was backed by Yuanming Capital, EFung Capital and Grains Valley Venture Capital and 2 others.
What stage is Ascentage Pharma at?
Ascentage Pharma's latest named round is a Series B, in Jan 2017.
Where is Ascentage Pharma based?
Ascentage Pharma is based in Hong Kong SAR China.
Companies like Ascentage Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.